Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Board restructuring

9 May 2013 07:00

RNS Number : 2953E
First Derivatives PLC
09 May 2013
 



First Derivatives plc

("First Derivatives" or the "Company")

 

Establishment of Executive Management Committee and restructuring of Board of Directors

 

First Derivatives (AIM: FDP.L, ESM: GYQ.I), a leading provider of software and consulting services to the capital markets industry, announced today that the board has recently completed a review of the Company's decision making processes and announces the creation of an Executive Management Committee and a restructuring of the Company's Board of Directors.

 

First Derivatives floated on AIM in March 2002 and has since grown revenues from ÂŁ1.8 million to ÂŁ46.1m in the year to February 2012. During this period the Company has expanded from a single office in Newry, Co Down, employing 26 members of staff, to a global network of 10 offices employing over 720 people.

 

The Company is well positioned for continued expansion and further growth. In anticipation of this further growth the board has created a new management structure appropriate for a rapidly growing international business.

 

The board believes that the reorganisation of directors' and management's responsibilities better reflects the operational structure of the Company and also more closely reflects the provisions of the UK Corporate Governance Code.

 

Group management responsibilities will now be conducted through the recently-created Executive Management Committee. The composition of the Executive Management Committee reflects the organisational structure and central functions of the Company and is comprised of Brian Conlon, Graham Ferguson, Adrian Toner, Kevin Cunningham, Brendan Duffy, Gerry Buggy and Tom Kozlowski.

 

First Derivatives' Board of Directors will remain responsible for the strategic development of the Company, for all matters of corporate governance and related shareholder matters.

 

The Board will comprise:

David Anderson Non-Executive Chairman

Brian Conlon Chief Executive Officer

Graham Ferguson Chief Finance Officer

Pat Brazel Non-Executive Director

Keith MacDonald Non-Executive Director

Seamus Keating Non-Executive Director

 

Therefore, with immediate effect Adrian Toner and Kevin Cunningham, will resign as directors of the Company but will remain members of the Executive Management Committee.

 

Michael O'Neill will also resign with immediate effect from the Board of Directors. Michael joined First Derivatives in 1997, soon after its formation, and was instrumental in helping build the business to its current scale and global presence from both an operational and strategic perspective. He remained an Executive Director until 2009, and has continued since then to serve as a Non-Executive Director while developing his own business interests.

 

Commenting on Michael's resignation, Chief Executive Brian Conlon said: "I would like to thank Michael for the great service he has provided to First Derivatives over the last 16 years. The Company has grown beyond all recognition and Michael's vision and drive helped transform the Company from a small consulting organisation to a listed global software and services Company with a market capitalisation of more than ÂŁ100m."

 

The board has also reviewed and amended the composition of the Remuneration Committee, as a result of which Brian Conlon will stand down and the committee will now comprise Pat Brazel (Chairman), Seamus Keating and David Anderson. The Audit Committee will comprise of Keith MacDonald (Chairman), Pat Brazel and Seamus Keating.

 

Commenting on the management restructuring David Anderson, Chairman, stated: "These changes address the need for a greater degree of structure and management flexibility within the Company as First Derivatives continues to expand into a global operating business. At the same time the board believes that the new structure also addresses the need for the Company to meet its obligations towards staff, shareholders and customers through more exacting standards of strong corporate governance."

 

 

For further information please contact:

 

First Derivatives plc +44(0)28 3025 2242

Brian Conlon, Chief Executive www.firstderivatives.com

Graham Ferguson, Chief Financial Officer

 

Charles Stanley Securities

(Nominated Adviser and Broker) +44 (0)20 7149 6000

Russell Cook

Carl Holmes

 

Goodbody Corporate Finance

(ESM Adviser and Broker) +353 1 667 0420

Diane Hodgson

Linda Hickey

 

Walbrook PR +44 (0)20 7933 8780

Bob Huxford bob.huxford@walbrookpr.com

Paul Cornelius paul.cornelius@walbrookir.com

 

 

About First Derivatives

First Derivatives is a global provider of software and consulting services to the financial services industry. With over 16 years experience working with leading financial institutions, it continues to deliver technologically advanced products and services that anticipate and respond to the evolving needs of global capital markets.

 

First Derivatives currently employs over 720 people worldwide and counts many of the world's top investment banks, brokers and hedge funds as its customers. It has operations in London, New York, Stockholm, Shanghai, Singapore, Toronto, Sydney, Dublin, Newry and Hong Kong.

 

For further information please visit www.firstderivatives.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBLGDULUGBGXI
Date   Source Headline
7th Mar 20167:00 amRNSEnterprise Securities Market Notice
1st Mar 20164:14 pmRNSIssue of Equity
29th Jan 20169:46 amRNSTotal Voting Rights
25th Jan 20167:00 amRNSEnterprise Securities Market Notice
22nd Jan 20163:31 pmRNSDirector/PDMR Shareholding
19th Jan 20163:28 pmRNSIssue of Equity
19th Jan 201611:16 amRNSDirector's Shareholding
19th Jan 201610:39 amRNSHolding(s) in Company
15th Jan 20167:00 amRNSEnterprise Securities Market Notice
14th Jan 20167:00 amRNSMOU with Utilismart
13th Jan 20163:25 pmRNSHolding(s) in Company
12th Jan 20167:00 amRNSFD acquires QuantumKDB
31st Dec 20157:00 amRNSTotal Voting Rights
7th Dec 20157:00 amRNSEnterprise Securities Market Notice
3rd Dec 20155:00 pmRNSHolding(s) in Company
1st Dec 20154:49 pmRNSIssue of Equity from exercise of Share Options
11th Nov 20157:00 amRNSHalf Yearly Report
2nd Nov 20157:00 amRNSContract win with National Stock Exchange of India
19th Oct 20157:00 amRNSNotice of Results and Trading Update
30th Sep 20151:33 pmRNSTotal Voting Rights
23rd Sep 20154:46 pmRNSIssue of Equity
16th Sep 20153:07 pmRNSHolding(s) in Company
10th Sep 20157:00 amRNSFormation of FD Labs
28th Aug 20157:00 amRNSTotal Voting Rights
6th Aug 20157:00 amRNSEnterprise Securities Market Notice
3rd Aug 20157:00 amRNSAppointment of Non-Executive Director
31st Jul 201511:22 amRNSIssue of Equity
31st Jul 201511:19 amRNSTotal Voting Rights
21st Jul 20153:22 pmRNSDirector/PDMR Shareholding
7th Jul 20155:31 pmRNSIssue of Equity from exercise of Share Options
25th Jun 20152:02 pmRNSResult of AGM
12th Jun 20155:15 pmRNSDirector's Shareholding
2nd Jun 20157:00 amRNSPreliminary Results
29th May 20154:59 pmRNSTotal Voting Rights
11th May 20157:00 amRNSChange of Adviser and Notice of Results
8th Apr 20157:00 amRNSEnterprise Securities Market Notice
1st Apr 201511:09 amRNSTotal Voting Rights
1st Apr 20157:00 amRNSFD acquires Affinity Systems for up to GBP7.7m
27th Mar 20157:00 amRNSEnterprise Securities Market Notice
24th Mar 20157:01 amRNSDirectorate Change and Appointment
24th Mar 20157:00 amRNSFD acquires ActivateClients Limited
19th Mar 20157:00 amRNSEnterprise Securities Market Notice
13th Mar 20154:29 pmRNSIssue of Equity
4th Mar 20157:00 amRNSEnterprise Securities Market Notice
4th Mar 20157:00 amRNSEnterprise Securities Market Notice
3rd Mar 20152:00 pmRNSFirst Derivatives strengthens board of Directors
3rd Mar 201511:06 amRNSResult of General Meeting
27th Feb 201511:27 amRNSTotal Voting Rights
26th Feb 20157:01 amRNSFD acquires Prelytix for up to USD20million
23rd Feb 20157:00 amRNSEnterprise Securities Market Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.